| 1 | Effect of physiotherapy on vital capacity before major abdom… (10.20471/lo.2021.49.01.05) | Abstract References ORCID License | 84.51 | 6 |
| 2 | Obesity and cancer (10.20471/lo.2020.48.02-03.16) | References ORCID License | 58.36 | 5 |
| 3 | Rare case of invasive lobular breast cancer metastasis to th… (10.20471/lo.2020.48.02-03.19) | References ORCID License | 58.36 | 5 |
| 4 | Rare metastasis of breast cancer to mandible - a case report (10.20471/lo.2018.46.02-03.20) | Abstract References ORCID License | 47.71 | 2 |
| 5 | Platelet-rich autoplazma effect on intestinal anastomosis re… (10.20471/lo.2019.47.02-03.11) | Abstract References ORCID License | 47.71 | 2 |
| 6 | Guided imagery and music in the preoperative period and duri… (10.20471/lo.2019.47.02-03.15) | Abstract References ORCID License | 47.71 | 2 |
| 7 | Effects of hydrogen-rich water on hamsters with experimental… (10.20471/lo.2023.51.02-03.13) | Abstract References ORCID License | 47.71 | 2 |
| 8 | Psychiatric disorders in patients with neurofibromatosis (10.20471/lo.2018.46.02-03.17) | Abstract References License | 35.78 | 2 |
| 9 | The impact of COVID-19 epidemiological restriction guideline… (10.20471/lo.2020.48.02-03.08) | References ORCID License | 35.78 | 2 |
| 10 | Characteristics of breast cancer in BRCA1/BRCA2 mutation car… (10.20471/lo.2020.48.02-03.10) | References ORCID License | 35.78 | 2 |
| 11 | Initial experiences comparing CT-guided radiofrequency and m… (10.20471/lo.2018.46.01.02) | Abstract References ORCID License | 30.10 | 1 |
| 12 | Uveal melanoma: an overview of management and prognosis (10.20471/lo.2018.46.02-03.16) | Abstract References ORCID License | 30.10 | 1 |
| 13 | First-line treatment of ovarian cancer FIGO stages IIIB-IV:… (10.20471/lo.2019.47.02-03.12) | Abstract References ORCID License | 30.10 | 1 |
| 14 | Modern radiotherapy techniques (10.20471/lo.2019.47.02-03.17) | Abstract References ORCID License | 30.10 | 1 |
| 15 | Abscopal effect of radiotherapy: an old concept in a new era (10.20471/lo.2020.48.01.05) | Abstract References ORCID License | 30.10 | 1 |
| 16 | COVID-19 and colorectal cancer – signs of a toxic relationsh… (10.20471/lo.2021.49.01.01) | Abstract References ORCID License | 30.10 | 1 |
| 17 | Microbiome and cancer (10.20471/lo.2021.49.02-03.18) | Abstract References ORCID License | 30.10 | 1 |
| 18 | Dosimetric analysis of treatment planning optimization techn… (10.20471/lo.2022.50.01.02) | Abstract References ORCID License | 30.10 | 1 |
| 19 | Treatment outcomes of patients with brca-mutated, recurrent… (10.20471/lo.2022.50.01.04) | Abstract References ORCID License | 30.10 | 1 |
| 20 | Undifferentiated carcinoma of the pancreas with osteoclast-l… (10.20471/lo.2022.50.01.07) | Abstract References ORCID License | 30.10 | 1 |
| 21 | National colorectal cancer early detection program and color… (10.20471/lo.2023.51.02-03.14) | Abstract References ORCID License | 30.10 | 1 |
| 22 | National Colorectal Cancer Early Detection Program: overview… (10.20471/lo.2024.52.01.04) | Abstract References ORCID License | 30.10 | 1 |
| 23 | Synchronous presentation of papillary thyroid carcinoma and… (10.20471/lo.2024.52.01.05) | Abstract References ORCID License | 30.10 | 1 |
| 24 | Trastuzumab and cardiotoxicity (10.20471/lo.2024.52.02-03.16) | Abstract References ORCID License | 30.10 | 1 |
| 25 | The role of metallothionein in breast cancer (10.20471/lo.2022.50.02-03.16) | References License | 23.86 | 2 |
| 26 | Prognostic significance of radiation induced lymphopenia in… (10.20471/lo.2018.46.02-03.09) | Abstract References License | 22.58 | 1 |
| 27 | First-line treatment of advanced ovarian cancer: an expert u… (10.20471/lo.2020.48.02-03.14) | References ORCID License | 22.58 | 1 |
| 28 | Resonance imaging on the surgical management of newly diagno… (10.20471/lo.2022.50.02-03.17) | References License | 15.05 | 1 |
| 29 | Role of radiotherapy in the treatment of locally advanced pe… (10.20471/lo.2022.50.02-03.23) | References License | 15.05 | 1 |
| 30 | Results of multicenter testing of PIK3CA somatic mutations i… (10.20471/lo.2023.51.01.01) | References License | 15.05 | 1 |
| 31 | Breast cancer radiotherapy - changes in fractionation scheme… (10.20471/lo.2023.51.01.03) | References License | 15.05 | 1 |
| 32 | Rare case of early-onset drain-site hernia after laparoscopi… (10.20471/lo.2018.46.01.03) | Abstract References ORCID License | 0.00 | 0 |
| 33 | Driver mutations in melanoma (10.20471/lo.2018.46.01.04) | Abstract References ORCID License | 0.00 | 0 |
| 34 | Taxanes in adjuvant breast cancer treatment (10.20471/lo.2018.46.01.05) | Abstract References ORCID License | 0.00 | 0 |
| 35 | Hormone receptor expression and ribociclib activity in hormo… (10.20471/lo.2018.46.01.06) | Abstract References ORCID License | 0.00 | 0 |
| 36 | Association of inflammatory status of patients with histopat… (10.20471/lo.2018.46.02-03.07) | Abstract References ORCID License | 0.00 | 0 |
| 37 | Regional differences of breast cancer risk factors in newly… (10.20471/lo.2018.46.02-03.08) | Abstract References ORCID License | 0.00 | 0 |
| 38 | Organizational model of palliative care in the Republic of C… (10.20471/lo.2018.46.02-03.10) | Abstract References ORCID License | 0.00 | 0 |
| 39 | Association of tumor cells chemoresistance mechanisms and su… (10.20471/lo.2018.46.02-03.11) | Abstract References ORCID License | 0.00 | 0 |
| 40 | Adjuvant radiotherapy of breast cancer - is partial breast i… (10.20471/lo.2018.46.02-03.12) | Abstract References ORCID License | 0.00 | 0 |
| 41 | Management of young women with early breast cancer – focus o… (10.20471/lo.2018.46.02-03.13) | Abstract References ORCID License | 0.00 | 0 |
| 42 | Pregnancy associated breast cancer (10.20471/lo.2018.46.02-03.14) | Abstract References ORCID License | 0.00 | 0 |
| 43 | Optimal treatment of patients with high-risk prostate cancer (10.20471/lo.2018.46.02-03.15) | Abstract References License | 0.00 | 0 |
| 44 | An argument for one day follow-up in cancer care (10.20471/lo.2018.46.02-03.18) | Abstract References ORCID License | 0.00 | 0 |
| 45 | Radiation-induced angiosarcoma of the breast - four case rep… (10.20471/lo.2018.46.02-03.19) | Abstract References License | 0.00 | 0 |
| 46 | The difference between left and right colon cancer patients’… (10.20471/lo.2019.47.02-03.08) | Abstract References ORCID License | 0.00 | 0 |
| 47 | Treatment results of metastatic kidney cancer patients inclu… (10.20471/lo.2019.47.02-03.09) | Abstract References ORCID License | 0.00 | 0 |
| 48 | Assessment of nutritional risk in cancer patients treated wi… (10.20471/lo.2019.47.02-03.10) | Abstract References License | 0.00 | 0 |
| 49 | Analysis of intermediate and poor prognostic group of patien… (10.20471/lo.2019.47.02-03.13) | Abstract References ORCID License | 0.00 | 0 |
| 50 | Overview of surgical gastric cancer treatment according to t… (10.20471/lo.2019.47.02-03.14) | Abstract References License | 0.00 | 0 |